Assessment of selected adipocytokines in obese women with postmenopausal osteoporosis.
Osteoporosis and obesity are considered civilization diseases. Menopause is a time of increased bone resorption and an increase in the mass of adipose tissue. Adipocytokines secreted by the adipose tissue are believed to be a potential factor in the pathogenesis of osteoporosis. The aim of this research was to assess leptin, adiponectin and resistin secretion in obese postmenopausal women with osteoporosis and determine whether obesity might be a factor mitigating the risk of osteoporosis. The study involved 80 postmenopausal women with osteoporosis divided into groups: I with the BMI of 30.0-34.9, obese and II with the BMI of 18-24.9, normoweight. Leptin, adiponectin and resistin concentrations were assessed and bone mineral density (BMD) was measured in the L1-L4 section of the spine using the DXA densitometric method. The results of the comparison of the two groups indicate a statistically significant dependence in groups regarding leptin secretion; the group of obese women demonstrated significantly higher concentrations. No differences between the groups were demonstrated for adiponectin or resistin secretion. Higher leptin concentration and a positive correlation with BMI was confirmed in obese postmenopausal women with osteoporosis. It was also demonstrated that BMD increases with growing BMI. No effect of obesity on the secretion of adiponectin or resistin in women with postmenopausal osteoporosis was found. From among the investigated adipocytokines, only leptin can be considered a bone tissue protective factor in postmenopausal women.